289 related articles for article (PubMed ID: 33810567)
1. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer.
Onyeisi JOS; Lopes CC; Götte M
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810567
[TBL] [Abstract][Full Text] [Related]
2. microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
Onyeisi JOS; Greve B; Espinoza-Sánchez NA; Kiesel L; Lopes CC; Götte M
J Cell Biochem; 2021 Oct; 122(10):1491-1505. PubMed ID: 34180077
[TBL] [Abstract][Full Text] [Related]
3. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
4. Role of syndecan-4 in breast cancer pathophysiology.
Onyeisi JOS; Lopes CC; Götte M
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1345-C1354. PubMed ID: 36094435
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells.
Carneiro BR; Pernambuco Filho PC; Mesquita AP; da Silva DS; Pinhal MA; Nader HB; Lopes CC
PLoS One; 2014; 9(12):e116001. PubMed ID: 25549223
[TBL] [Abstract][Full Text] [Related]
6. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
[TBL] [Abstract][Full Text] [Related]
7. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656
[TBL] [Abstract][Full Text] [Related]
9. Alpha-actinin interactions with syndecan-4 are integral to fibroblast-matrix adhesion and regulate cytoskeletal architecture.
Okina E; Grossi A; Gopal S; Multhaupt HA; Couchman JR
Int J Biochem Cell Biol; 2012 Dec; 44(12):2161-74. PubMed ID: 22940199
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.
Chalkiadaki G; Nikitovic D; Berdiaki A; Sifaki M; Krasagakis K; Katonis P; Karamanos NK; Tzanakakis GN
Int J Biochem Cell Biol; 2009 Jun; 41(6):1323-31. PubMed ID: 19110070
[TBL] [Abstract][Full Text] [Related]
11. Trans-regulation of Syndecan Functions by Hetero-oligomerization.
Choi Y; Kwon MJ; Lim Y; Yun JH; Lee W; Oh ES
J Biol Chem; 2015 Jul; 290(27):16943-53. PubMed ID: 25979339
[TBL] [Abstract][Full Text] [Related]
12. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
[TBL] [Abstract][Full Text] [Related]
13. Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance.
Onyeisi JOS; Pernambuco Filho PCA; Mesquita APS; Azevedo LC; Nader HB; Lopes CC
Int J Biochem Cell Biol; 2020 Nov; 128():105848. PubMed ID: 32927086
[TBL] [Abstract][Full Text] [Related]
14. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of syndecan-4 protein expression in colorectal cancer.
Jechorek D; Haeusler-Pliske I; Meyer F; Roessner A
Pathol Res Pract; 2021 Jun; 222():153431. PubMed ID: 34029877
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
[TBL] [Abstract][Full Text] [Related]
17. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2.
Song SJ; Cool SM; Nurcombe V
J Cell Biochem; 2007 Feb; 100(2):402-11. PubMed ID: 16924669
[TBL] [Abstract][Full Text] [Related]
18. Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.
Manon-Jensen T; Multhaupt HA; Couchman JR
FEBS J; 2013 May; 280(10):2320-31. PubMed ID: 23384311
[TBL] [Abstract][Full Text] [Related]
19. Myoblast Migration and Directional Persistence Affected by Syndecan-4-Mediated Tiam-1 Expression and Distribution.
Becsky D; Gyulai-Nagy S; Balind A; Horvath P; Dux L; Keller-Pinter A
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012800
[TBL] [Abstract][Full Text] [Related]
20. Syndecan proteoglycan contributions to cytoskeletal organization and contractility.
Okina E; Manon-Jensen T; Whiteford JR; Couchman JR
Scand J Med Sci Sports; 2009 Aug; 19(4):479-89. PubMed ID: 19538537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
